Armata Pharmaceuticals, Inc. (NYSE American: ARMP) has received $3.7 million in non-dilutive funding from the U.S. Department of War to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE